Furthermore, the independent verification data as well as our RT-qPCR results also revealed that CAD patients had significantly raised ITGAM, TYROBP, ICAM1 and CAMP expression levels in contrast to healthy subjects. This evidence concerns the gene TYROBP and coronary artery disorder.